CSNK1E
MOLECULAR TARGETcasein kinase 1 epsilon
CSNK1E (casein kinase 1 epsilon) is targeted by 37 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CSNK1E
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gefitinib | 5.67 | 290 |
| 2 | erlotinib | 5.55 | 256 |
| 3 | epigalocatechin gallate | 5.40 | 220 |
| 4 | sb 203580 | 4.92 | 136 |
| 5 | seliciclib | 4.91 | 135 |
| 6 | foretinib | 4.34 | 76 |
| 7 | vandetanib | 4.30 | 73 |
| 8 | bosutinib | 4.08 | 58 |
| 9 | bi 2536 | 4.01 | 54 |
| 10 | neratinib | 3.66 | 38 |
| 11 | sb 202190 | 3.64 | 37 |
| 12 | nintedanib | 3.61 | 36 |
| 13 | canertinib | 3.53 | 33 |
| 14 | pelitinib | 3.50 | 32 |
| 15 | bms 387032 | 3.47 | 31 |
| 16 | cgs 15943 | 3.47 | 31 |
| 17 | sb 431542 | 3.33 | 27 |
| 18 | sp 600125 | 3.22 | 24 |
| 19 | jnj 7706621 | 3.09 | 21 |
| 20 | galunisertib | 2.94 | 18 |
| 21 | cediranib | 2.83 | 16 |
| 22 | milciclib | 2.77 | 15 |
| 23 | pha 665752 | 2.71 | 14 |
| 24 | kw 2449 | 2.64 | 13 |
| 25 | ast 487 | 2.56 | 12 |
| 26 | su 014813 | 2.20 | 8 |
| 27 | cyc 116 | 2.08 | 7 |
| 28 | tg100 115 | 2.08 | 7 |
| 29 | umbralisib | 2.08 | 7 |
| 30 | osi 632 | 1.79 | 5 |
| 31 | tak 715 | 1.79 | 5 |
| 32 | egcg | 0.69 | 1 |
| 33 | Afatinib | 0.69 | 1 |
| 34 | Dasatinib | 0.69 | 1 |
| 35 | Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is | 0.69 | 1 |
| 36 | pictilisib | 0.69 | 1 |
| 37 | sp600125 | 0.69 | 1 |
About CSNK1E as a Drug Target
CSNK1E (casein kinase 1 epsilon) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 37 compounds with documented CSNK1E interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CSNK1E inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.